- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CDRH names permanent director
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agency’s Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agencys Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and acting director Elizabeth Jacobson (SCAN 3/3/99). Feigals new position is effective immediately.
Feigal joined the FDA in 1992, and has served as head of the Center for Drug Evaluation and Researchs division of antiviral drug products and as medical deputy director of the FDAs Center for Biologics Evaluation and Research. He was a principal investigator in studies that led the FDA to approve a drug-device combination that was one of the earliest therapies for AIDS.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
